GlassScriptPhysician profile
Deepa Rajiv
NPI 1891808390
$581.35
in general payments reported to CMS, 2019-2025
6 companies · $123 in 2025
The $123 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $245 · 2020: $54.16 · 2021: $138 · 2024: $20.49 · 2025: $123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $143.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $143.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $301.50 | 2019-2025 | |
| Glaxosmithkline, LLC. | $194.24 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $27.08 | 2019-2020 | |
| Lilly USA, LLC | $24.71 | 2019-2020 | |
| Boston Scientific Corporation | $20.49 | 2024 | |
| Amarin Pharma, INC. | $13.33 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deepa Rajiv listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.